HAGO 2020 - Heartland Association for Gynecologic Oncology (Virtual Meeting)
Sep 10 - Sep 11, 2020 | Wisconsin RapidsWIUS
LARVOL is not affiliated with Heartland Association for Gynecologic Oncology (Virtual Meeting) and all trademarks, logos, and brand names are property of their respective owners
Showing 5 abstracts linked to Trials
[VIRTUAL] Evaluation of an individualized starting dose of niraarib in the PRIMA/ENGOT-OV26/GOG-3012 study
[VIRTUAL] Efficacy of niraparib therapy in patients with newly diagnosed advanced ovarian cancer by BRCA and homologous recombination status: PRIMA/ENGOT-OV26/GOG-3012 study
[VIRTUAL] Patient-reported outcomes in patients receiving niraparib in the PRIMA/ENGOT-OV26/GOG-3012 trial
[VIRTUAL] Safety and efficacy of the anti-PD-1 monoclonal antibody dostarlimab in patients with recurrent or advanced dMMR endometrial cancer
[VIRTUAL] Patient-reported outcomes in the GARNET trial in patients with advanced or recurrent dMMR/MSI-H endometrial cancer treated with dostarlimab